These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1601 related articles for article (PubMed ID: 27655588)
1. The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis. Bonde JP; Flachs EM; Rimborg S; Glazer CH; Giwercman A; Ramlau-Hansen CH; Hougaard KS; Høyer BB; Hærvig KK; Petersen SB; Rylander L; Specht IO; Toft G; Bräuner EV Hum Reprod Update; 2016 Dec; 23(1):104-125. PubMed ID: 27655588 [TBL] [Abstract][Full Text] [Related]
2. Prenatal and postnatal exposures to endocrine disrupting chemicals and timing of pubertal onset in girls and boys: a systematic review and meta-analysis. Uldbjerg CS; Koch T; Lim YH; Gregersen LS; Olesen CS; Andersson AM; Frederiksen H; Coull BA; Hauser R; Juul A; Bräuner EV Hum Reprod Update; 2022 Aug; 28(5):687-716. PubMed ID: 35466359 [TBL] [Abstract][Full Text] [Related]
3. Temporal decline of sperm concentration: role of endocrine disruptors. Cannarella R; Gül M; Rambhatla A; Agarwal A Endocrine; 2023 Jan; 79(1):1-16. PubMed ID: 36194343 [TBL] [Abstract][Full Text] [Related]
4. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union. Hauser R; Skakkebaek NE; Hass U; Toppari J; Juul A; Andersson AM; Kortenkamp A; Heindel JJ; Trasande L J Clin Endocrinol Metab; 2015 Apr; 100(4):1267-77. PubMed ID: 25742517 [TBL] [Abstract][Full Text] [Related]
5. Exposure to non-persistent chemicals in consumer products and fecundability: a systematic review. Hipwell AE; Kahn LG; Factor-Litvak P; Porucznik CA; Siegel EL; Fichorova RN; Hamman RF; Klein-Fedyshin M; Harley KG; Hum Reprod Update; 2019 Jan; 25(1):51-71. PubMed ID: 30307509 [TBL] [Abstract][Full Text] [Related]
6. Per- and polyfluoroalkyl substances and male reproductive health: a systematic review of the epidemiological evidence. Petersen KU; Larsen JR; Deen L; Flachs EM; Hærvig KK; Hull SD; Bonde JPE; Tøttenborg SS J Toxicol Environ Health B Crit Rev; 2020 Aug; 23(6):276-291. PubMed ID: 32741292 [TBL] [Abstract][Full Text] [Related]
7. Regional differences and temporal trends in male reproductive health disorders: semen quality may be a sensitive marker of environmental exposures. Nordkap L; Joensen UN; Blomberg Jensen M; Jørgensen N Mol Cell Endocrinol; 2012 May; 355(2):221-30. PubMed ID: 22138051 [TBL] [Abstract][Full Text] [Related]
8. Endocrine Disrupting Chemicals and Reproductive Health in Boys and Men. Rodprasert W; Toppari J; Virtanen HE Front Endocrinol (Lausanne); 2021; 12():706532. PubMed ID: 34690925 [TBL] [Abstract][Full Text] [Related]
10. Endocrine disruptors and the male reproductive system. Stukenborg JB; Mitchell RT; Söder O Best Pract Res Clin Endocrinol Metab; 2021 Sep; 35(5):101567. PubMed ID: 34426080 [TBL] [Abstract][Full Text] [Related]
11. Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection. Toppari J; Virtanen HE; Main KM; Skakkebaek NE Birth Defects Res A Clin Mol Teratol; 2010 Oct; 88(10):910-9. PubMed ID: 20865786 [TBL] [Abstract][Full Text] [Related]
12. Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence. Baldacci S; Gorini F; Santoro M; Pierini A; Minichilli F; Bianchi F Epidemiol Prev; 2018; 42(3-4 Suppl 1):1-34. PubMed ID: 30066535 [TBL] [Abstract][Full Text] [Related]
13. Contribution of prenatal endocrine-disrupting chemical exposure to genital anomalies in males: The pooled results from current evidence. Wu Y; Wang J; Wei Y; Chen J; Kang L; Long C; Wu S; Shen L; Wei G Chemosphere; 2022 Jan; 286(Pt 3):131844. PubMed ID: 34392196 [TBL] [Abstract][Full Text] [Related]
14. Parental occupational exposure to endocrine disrupting chemicals and male genital malformations: a study in the Danish National Birth Cohort study. Morales-Suárez-Varela MM; Toft GV; Jensen MS; Ramlau-Hansen C; Kaerlev L; Thulstrup AM; Llopis-González A; Olsen J; Bonde JP Environ Health; 2011 Jan; 10(1):3. PubMed ID: 21235764 [TBL] [Abstract][Full Text] [Related]
16. Effect of environmental and pharmaceutical exposures on fetal testis development and function: a systematic review of human experimental data. Kilcoyne KR; Mitchell RT Hum Reprod Update; 2019 Jul; 25(4):397-421. PubMed ID: 30869130 [TBL] [Abstract][Full Text] [Related]
17. Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies. Storgaard L; Bonde JP; Olsen J Reprod Toxicol; 2006 Jan; 21(1):4-15. PubMed ID: 16005180 [TBL] [Abstract][Full Text] [Related]
18. Endocrine Disrupting Chemicals and Risk of Testicular Cancer: A Systematic Review and Meta-analysis. Bräuner EV; Lim YH; Koch T; Uldbjerg CS; Gregersen LS; Pedersen MK; Frederiksen H; Petersen JH; Coull BA; Andersson AM; Hickey M; Skakkebæk NE; Hauser R; Juul A J Clin Endocrinol Metab; 2021 Nov; 106(12):e4834-e4860. PubMed ID: 34270734 [TBL] [Abstract][Full Text] [Related]
19. Testicular dysgenesis syndrome: possible role of endocrine disrupters. Bay K; Asklund C; Skakkebaek NE; Andersson AM Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):77-90. PubMed ID: 16522521 [TBL] [Abstract][Full Text] [Related]
20. Endocrine disrupting chemicals and their effects on the reproductive health in men. Thacharodi A; Hassan S; Acharya G; Vithlani A; Hoang Le Q; Pugazhendhi A Environ Res; 2023 Nov; 236(Pt 2):116825. PubMed ID: 37544467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]